Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 19 results found. Search for [ Covishield dosage ]

Results 1 to 19 of 19
BusinessToday.In
March 22, 2021
The Centre said that protection is enhanced if the second dose of Covishield is administered between 6-8 weeks but not later than a period of 8 weeks


BusinessToday.In
March 18, 2021
Addressing a press conference, Health Secretary Rajesh Bhushan said on Wednesday that 3.51 crore vaccine doses have been administered till now in the country


BusinessToday.In
March 2, 2021
As senior citizens across the country take part in the vaccination drive, here is all the information they need two know about the two vaccines - Covaxin and Covishield


BusinessToday.In
February 19, 2021
In this meeting, the NTAGI will review the World Health Organisation's (WHO) recommendation to extend the gap between two doses of the AstraZeneca- Oxford vaccine from 4 weeks to 8-12 weeks


BusinessToday.In
January 24, 2021
Coronavirus vaccine: Additionally, nine out of the 10 cases occurred in patients with previously known allergies. It is still not clear what caused these reaction


BusinessToday.In
January 16, 2021
In the first phase of the vaccination drive over 3 crores frontline healthcare workers are expected to be given the vaccine. They will receive either Covaxin or Covishield COVID-19 vaccines which were approved for emergency use earlier by the country's drug regulators


BusinessToday.In
January 16, 2021
Coronavirus vaccination drive: It brings me great pride that Covishield is part of this historic effort, said Serum Institute CEO Adar Poonawalla


BusinessToday.In
January 15, 2021
The Union Health Ministry also said if required, COVID-19 vaccine and other vaccines should be separated by an interval of at least 14 days


BusinessToday.In
January 4, 2021
Coronavirus vaccine in India: Adar Poonawalla, CEO of Serum Institute of India that is manufacturing Covishield had said that the company is ready to roll out its vaccine in the coming weeks


BusinessToday.In
December 29, 2020
Serum Institute of India (SII) CEO Adar Poonawalla said on December 28, that the vaccine is likely to get an emergency-use licence from the UK Medicines and Healthcare products Regulatory Agency as well as the Indian regulator, Drugs Controller General of India (DCGI), by early January


BusinessToday.In
December 19, 2020
SII had earlier said its vaccine candidate showed 90 per cent efficacy rate at a full dose plus a half dose regimen, while a 62 per cent efficacy rate at full two-dose regimen


BusinessToday.In
December 13, 2020
David Prior says next three months are going to be extremely difficult and the world is pinning hopes on vaccine; Serum Institute also hopes to get approval for emergency use in India soon after nod in the UK


BusinessToday.In
December 11, 2020
The regulatory approval in the UK is crucial to strengthen SII's application seeking emergency use authorisation in India because the proposal here refers to trials being conducted in the UK and Brazil


BusinessToday.In
December 9, 2020
Several experts have raised questions about Bharat Biotech applying for emergency usage as Covaxin is still going through an efficacy trial. However, the ICMR has backed Bharat Biotech's move


BusinessToday.In
November 29, 2020
Serum Institute of India's (SII) CEO Adar Poonawalla made the announcement hours after a meeting with Prime Minister Narendra Modi, who visited Serum's plant in Pune on Saturday, November 28


BusinessToday.In
November 24, 2020
Serum Institute has tied up with British-Swedish pharmaceutical firm AstraZeneca and the University of Oxford to mass-produce the Covishield vaccine to fight back COVID-19 virus


BusinessToday.In
November 23, 2020
Earlier on Monday, the Oxford-AstraZeneca team announced that one of the dosing regimens of the vaccine might be 90% effective in preventing COVID-19 infection


BusinessToday.In
November 23, 2020
Vaccine can be easily manufactured, transported and stored at domestic fridge temperature (2-8 degrees C). This means it can be easily distributed using existing medical facilities such as doctor's surgeries and local pharmacies, allowing for the vaccine to be deployed very rapidly, said Oxford University


www.businesstoday.in
January 2, 2021
How will the Oxford vaccine be produced in India?


PAGES 1 OF 1